Screener
Eligibility screening
A Phase II Trial of Axicabtagene Ciloleucel with Radiation Therapy in Relapsed/Refractory Follicular Lymphoma
1 US site in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.